The Consortium of Multiple Sclerosis Centers (CMSC), a professional and educational organization for clinicians and researchers treating MS patients or studying MS, has issued a position statement asserting that prescribers must retain the right to decide on the best treatment and medication for each individual MS patient. The Consortium membership includes more than 7,000 international clinicians and researchers committed to MS care, more than 60 Veteran’s Administration MS programs, and 225 MS centers in the US, Canada, and Europe.